Abbott Laboratories Stock Price To Earning
ABT Stock | USD 107.53 0.67 0.63% |
Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
Abbott | Price To Earning |
Abbott Laboratories Company Price To Earning Analysis
Abbott Laboratories' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Abbott Laboratories Price To Earning | 24.14 X |
Most of Abbott Laboratories' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Abbott Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Abbott Stock properly, considering its historical fundamentals such as Price To Earning. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Abbott Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Abbott Laboratories has a Price To Earning of 24.14 times. This is 6.58% lower than that of the Health Care Equipment & Supplies sector and 65.45% lower than that of the Health Care industry. The price to earning for all United States stocks is 15.95% higher than that of the company.
Abbott Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in price to earning category among related companies.
Abbott Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Abbott Fundamentals
Return On Equity | 0.15 | ||||
Return On Asset | 0.0611 | ||||
Profit Margin | 0.14 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 194.29 B | ||||
Shares Outstanding | 1.74 B | ||||
Shares Owned By Insiders | 0.53 % | ||||
Shares Owned By Institutions | 77.03 % | ||||
Number Of Shares Shorted | 12.94 M | ||||
Price To Earning | 24.14 X | ||||
Price To Book | 4.90 X | ||||
Price To Sales | 4.72 X | ||||
Revenue | 40.11 B | ||||
Gross Profit | 24.58 B | ||||
EBITDA | 10.59 B | ||||
Net Income | 5.7 B | ||||
Cash And Equivalents | 9.88 B | ||||
Cash Per Share | 5.68 X | ||||
Total Debt | 15.87 B | ||||
Debt To Equity | 0.46 % | ||||
Current Ratio | 1.86 X | ||||
Book Value Per Share | 22.26 X | ||||
Cash Flow From Operations | 7.26 B | ||||
Short Ratio | 1.88 X | ||||
Earnings Per Share | 3.21 X | ||||
Price To Earnings To Growth | 5.99 X | ||||
Target Price | 126.69 | ||||
Number Of Employees | 114 K | ||||
Beta | 0.74 | ||||
Market Capitalization | 185.47 B | ||||
Total Asset | 73.21 B | ||||
Retained Earnings | 37.55 B | ||||
Working Capital | 8.83 B | ||||
Current Asset | 14.15 B | ||||
Current Liabilities | 9.19 B | ||||
Annual Yield | 0.02 % | ||||
Five Year Return | 1.54 % | ||||
Net Asset | 73.21 B | ||||
Last Dividend Paid | 2.12 |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Abbott Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving together with Abbott Stock
0.83 | GMED | Globus Medical Financial Report 2nd of May 2024 | PairCorr |
0.75 | IDXX | IDEXX Laboratories Financial Report 7th of May 2024 | PairCorr |
Moving against Abbott Stock
0.78 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
0.7 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
0.52 | ELYM | Eliem Therapeutics Upward Rally | PairCorr |
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.